005690.KS KSC
Pharmicell Co., Ltd.
1W: -1.1%
1M: +13.4%
3M: -8.9%
YTD: -16.3%
1Y: -5.8%
3Y: +72.4%
5Y: -30.6%
₩12,400.00 ($9.23)
-190.00 (-1.51%)
Weekly Expected Move ±6.9%
₩10694
₩11547
₩12400
₩13253
₩14106
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$41.1B
+1073.6% ▲
5Y CAGR: +35.5%
Capital Expenditures
$7.5B
-71.8% ▼
5Y CAGR: +58.6%
Free Cash Flow
$33.6B
+4100.3% ▲
5Y CAGR: +32.5%
Dividends Paid
$1.2B
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$20.6B
+476.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $9.5B | $10.9B | $3.6B | $6.3B | $40.3B |
| Depreciation & Amort. | $1.7B | $2.2B | $2.8B | $3.1B | $3.0B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$16.4B | -$5.5B | $3.4B | -$7.5B | -$96M |
| Other Non-Cash Items | -$29M | $344M | $2.0B | $1.6B | -$2.2B |
| Operating Cash Flow | -$5.2B | $7.9B | $11.8B | $3.5B | $41.1B |
| — Investing Activities — | |||||
| Capital Expenditures | -$4.3B | -$19.0B | -$6.0B | -$4.3B | -$7.5B |
| Acquisitions (Net) | $28M | $4M | $2M | $0 | $10M |
| Investment Purchases | -$5.4B | -$15.6B | -$16.1B | -$5.6B | -$70M |
| Investment Sales | $392M | $14.1B | $27.5B | $3.1B | $46M |
| Other Investing | -$38M | -$40M | $599M | -$60M | -$24.8B |
| Investing Cash Flow | -$9.3B | -$20.5B | $5.9B | -$6.8B | -$32.3B |
| — Financing Activities — | |||||
| Net Debt Issuance | $18.9B | $0 | -$18.4B | -$2.9B | $14.0B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | -$1.2B |
| Other Financing | -$373M | -$270M | -$318M | -$311M | -$323M |
| Financing Cash Flow | $18.5B | -$270M | -$18.7B | -$3.2B | $12.5B |
| Net Change in Cash | $5.3B | -$11.9B | -$635M | -$5.5B | $20.6B |
| Cash End of Period | $26.2B | $14.4B | $13.7B | $8.3B | $28.9B |
| Free Cash Flow | -$9.5B | -$11.0B | $5.8B | -$840M | $33.6B |